About
Calcimedica, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 3 2026
CalciMedica Reports 2025 Financial Results and Provides Clinical Updates
Jan 28 2026
CalciMedica Announces Discontinuation of Phase 2 KOURAGE Trial in AKI Following Independent Data Monitoring Committee Recommendation
Nov 12 2025
CalciMedica Reports Third Quarter 2025 Financial Results and Provides Clinical & Corporate Updates
Nov 12 2025
CalciMedica Announces Publication in JCI Insight of Preclinical Data Supporting CRAC Channel Inhibitor as a Potential Therapy for Pulmonary Arterial Hypertension
Nov 10 2025
CalciMedica Presents Data from Preclinical Study of Auxora™ in an Animal Model of AKI at ASN Kidney Week 2025
Recent Videos

CALC Stock Dips on Discontinuation of Phase 2 KOURAGE Trial of Auxora
Jan 28, 2026

CALC STOCK : READY TO EXPAND | CALCIMEDICA STOCK
Jan 20, 2026

CALC Biotech CalciMedica, Inc. Dylans Biotech Pick (12/28/2025)
Dec 29, 2025

Clover Reports Strong RSV Results | CalciMedica & Telperian Partner on AI – Clinical News Update
Oct 16, 2025
Translate